Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 96,459 | 71,416 | 85,522 | 53,583 | 86,338 |
| Cost of Goods | 3,542 | 3,006 | 3,211 | 2,376 | 3,761 |
| Gross Profit | 92,917 | 68,410 | 82,311 | 51,207 | 82,577 |
| Operating Expenses | 166,244 | 128,891 | 121,280 | 120,723 | 128,476 |
| Operating Income | -72,785 | -60,475 | -38,758 | -69,140 | -45,138 |
| Interest Expense | 5,463 | 2,666 | 2,074 | 2,288 | 3,249 |
| Other Income | 11,215 | 2,800 | -183 | -109 | -936 |
| Pre-tax Income | -67,033 | -60,341 | -41,015 | -71,537 | -49,323 |
| Income Tax | 10,644 | -344 | 774 | 576 | -994 |
| Net Income Continuous | -77,677 | -59,997 | -41,789 | -72,113 | -48,329 |
| Net Income | $-77,677 | $-59,997 | $-41,789 | $-72,113 | $-48,329 |
| EPS Basic Total Ops | -1.17 | -1.06 | -0.75 | -1.29 | -1.02 |
| EPS Basic Continuous Ops | -1.17 | -1.06 | -0.75 | -1.29 | -1.02 |
| EPS Diluted Total Ops | -1.17 | -1.06 | -0.75 | -1.29 | -1.02 |
| EPS Diluted Continuous Ops | -1.17 | -1.06 | -0.75 | -1.29 | -1.02 |
| EBITDA(a) | $-63,796 | $-52,645 | $-31,566 | $-62,199 | $-38,312 |